ITRM
Iterum Therapeutics plc
NASDAQ · Healthcare · Biotechnology · IE
$0.03
−10.98%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -0.19x
- Price / sales
- 3.52x
- Price / cash flow
- -0.07x
Enterprise value
- Enterprise value
- $24.1M
- EV / sales
- 61.81x
- EV / EBITDA
- -1.04x
- EV / EBIT
- -1.19x
- Market cap
- $1.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2025